Literature DB >> 25703331

The origin of breast tumor heterogeneity.

A Skibinski1,2, C Kuperwasser1,2.   

Abstract

How breast diversity is generated is a fascinating and fundamental question with important clinical implications. It is clear that the diversity of phenotypes displayed by breast cancer cells reflects the array of cell types present in the disease-free breast epithelium, including luminal, basal and stem cells. Therefore, it is hypothesized that the molecular regulators governing normal development of the breast epithelium may double as engines of breast tumor diversity. In the past few years, a deepened understanding of the mammary epithelial hierarchy has prompted the search for the cellular precursors of breast tumors. At the same time, the use of novel experimental strategies including the new technology of massively parallel sequencing has provided insight into the origin and evolution of breast tumors. Here, we review the current understanding of the basis of the intrinsic subtypes and the sources of inter-tumor heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25703331      PMCID: PMC4734640          DOI: 10.1038/onc.2014.475

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  87 in total

Review 1.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

2.  In situ identification of bipotent stem cells in the mammary gland.

Authors:  Anne C Rios; Nai Yang Fu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2014-01-26       Impact factor: 49.962

3.  The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.

Authors:  Adam Skibinski; Jerrica L Breindel; Aleix Prat; Patricia Galván; Elizabeth Smith; Andreas Rolfs; Piyush B Gupta; Joshua LaBaer; Charlotte Kuperwasser
Journal:  Cell Rep       Date:  2014-03-06       Impact factor: 9.423

4.  Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

Authors:  Sarah Schwitalla; Alexander A Fingerle; Patrizia Cammareri; Tim Nebelsiek; Serkan I Göktuna; Paul K Ziegler; Ozge Canli; Jarom Heijmans; David J Huels; Guenievre Moreaux; Rudolf A Rupec; Markus Gerhard; Roland Schmid; Nick Barker; Hans Clevers; Roland Lang; Jens Neumann; Thomas Kirchner; Makoto M Taketo; Gijs R van den Brink; Owen J Sansom; Melek C Arkan; Florian R Greten
Journal:  Cell       Date:  2012-12-27       Impact factor: 41.582

Review 5.  Mammary gland development.

Authors:  Hector Macias; Lindsay Hinck
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jul-Aug       Impact factor: 5.814

Review 6.  Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.

Authors:  Michael Herman Chui
Journal:  Int J Cancer       Date:  2012-09-28       Impact factor: 7.396

7.  Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.

Authors:  Lorenzo Melchor; Gemma Molyneux; Alan Mackay; Fiona-Ann Magnay; María Atienza; Howard Kendrick; Daniel Nava-Rodrigues; María Ángeles López-García; Fernanda Milanezi; Kirsty Greenow; David Robertson; José Palacios; Jorge S Reis-Filho; Matthew J Smalley
Journal:  J Pathol       Date:  2014-06       Impact factor: 7.996

8.  A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis.

Authors:  Qian Chen; Nailing Zhang; Ryan S Gray; Huili Li; Andrew J Ewald; Cynthia A Zahnow; Duojia Pan
Journal:  Genes Dev       Date:  2014-03-01       Impact factor: 11.361

Review 9.  Mammary stem cells and the differentiation hierarchy: current status and perspectives.

Authors:  Jane E Visvader; John Stingl
Journal:  Genes Dev       Date:  2014-06-01       Impact factor: 11.361

10.  Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers.

Authors:  Allison S Cleary; Travis L Leonard; Shelley A Gestl; Edward J Gunther
Journal:  Nature       Date:  2014-04-03       Impact factor: 49.962

View more
  66 in total

1.  Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.

Authors:  Danny R Welch
Journal:  Cancer Res       Date:  2016-01-03       Impact factor: 12.701

2.  Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Authors:  Wen Bu; Zhenyu Liu; Weiyu Jiang; Chandandeep Nagi; Shixia Huang; Dean P Edwards; Eunji Jo; Qianxing Mo; Chad J Creighton; Susan G Hilsenbeck; Andrew D Leavitt; Michael T Lewis; Stephen T C Wong; Yi Li
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

3.  Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.

Authors:  Zhijing Tan; Song Nie; Sean P McDermott; Max S Wicha; David M Lubman
Journal:  J Proteome Res       Date:  2017-01-20       Impact factor: 4.466

Review 4.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

5.  Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.

Authors:  Constantinos Giaginis; Anastasia Sampani; Iolly Kotta-Loizou; Ioanna Giannopoulou; Eugene Danas; Ekaterini Politi; Gerasimos Tsourouflis; Gregorios Kouraklis; Efstratios Patsouris; Antonios Keramopoulos; Lydia Nakopoulou; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2017-08-14       Impact factor: 3.201

6.  A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers.

Authors:  Anthony Ferrari; Anne-Sophie Sertier; Anne Vincent-Salomon; Xavier Pivot; Iris Pauporté; Pierre Saintigny; Daniel Birnbaum; Alain Viari
Journal:  Mol Cell Oncol       Date:  2016-09-12

7.  Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.

Authors:  Fengju Chen; Yiqun Zhang; Don L Gibbons; Benjamin Deneen; David J Kwiatkowski; Michael Ittmann; Chad J Creighton
Journal:  Clin Cancer Res       Date:  2018-02-09       Impact factor: 12.531

8.  Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.

Authors:  Leander Blaas; Fabio Pucci; Hendrik A Messal; Agneta B Andersson; E Josue Ruiz; Marco Gerling; Iyadh Douagi; Bradley Spencer-Dene; Alexandra Musch; Richard Mitter; Leena Bhaw; Richard Stone; Dorothee Bornhorst; Abdul K Sesay; Jos Jonkers; Gordon Stamp; Ilaria Malanchi; Rune Toftgård; Axel Behrens
Journal:  Nat Cell Biol       Date:  2016-10-31       Impact factor: 28.824

9.  Impact of progesterone on stem/progenitor cells in the human breast.

Authors:  Heidi N Hilton; Christine L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-08-08       Impact factor: 2.673

10.  The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation.

Authors:  Maria Polycarpou-Schwarz; Matthias Groß; Pieter Mestdagh; Johanna Schott; Stefanie E Grund; Catherina Hildenbrand; Joachim Rom; Sebastian Aulmann; Hans-Peter Sinn; Jo Vandesompele; Sven Diederichs
Journal:  Oncogene       Date:  2018-05-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.